Ilana Fogelman Email & Phone

Chief Executive Officer @ miCure Therapeutics

@ George Mason University

Acting Chief Executive Officer @ miCure Therapeutics

Co-founder and Scientific Advisor @ C2N Diagnostics

Co-Founder and VP of Clinical and Regulatory Affairs @ C2N Diagnostics

Co-founder and Chief Operating Officer @ LifeTech Research

Co-founding Managing Partner @ LifeTech Development Partners, LP

Biotech Analyst @ Merrill Lynch then Citigroup

Medical Reviewer @ Food and Drug Administration

Principal investigator @ National Institutes of Health

Principal Investigator on WHO grant @ State Health Secretariat,

1991 - 1993 Post Doctoral Research Fellowship @ Harvard School of Public Health

1991 - 1993 Post-Docotoral Research Fellowship @ Harvard Medical School

1988 - 1989 MPH, post-doctoral fellowships @ Harvard School of Public Health

1981 - 1986 MD @ USP - Universidade de São Paulo

Clinical Trials, Immunology, Business Strategy, Strategic Planning, Pharmaceuticals, Biotechnology, Life Sciences, Start-ups, Emerging Markets, International Business, Venture Capital, Product Development, Oncology, Technology Transfer, Regulatory Affairs, Market Analysis, Market Research, Competitive Analysis, Forecasting, Lifesciences, Infectious Diseases, Clinical Development, Pharmaceutical Industry, Due Diligence, Strategy, Competitive Intelligence, Monoclonal Antibodies, FDA, Clinical Research, Commercialization, Market Access, Cell, Drug Development, Medical Devices, Biopharmaceuticals, Vaccines, Pharmacovigilance, Regulatory Submissions, Cancer, IND, Corporate Development, Product Launch, Medicine, Development, Networking, Start Ups, Regulatory, U.S. Food And Drug Administration Fda, Biomarkers, Surveillance, u.s. Food and Drug Administration

Ilana Fogelman, based in Washington, DC, US, is currently a Chief Executive Officer at miCure Therapeutics. Ilana Fogelman brings experience from previous roles at George Mason University, miCure Therapeutics, C2N Diagnostics, C2N Diagnostics, LifeTech Research, LifeTech Development Partners, LP, Merrill Lynch then Citigroup, Food and Drug Administration, National Institutes of Health, State Health Secretariat,. Ilana Fogelman holds various educational qualifications including Post Doctoral Research Fellowship in HIV Clinical Trials (1991 - 1993) from Harvard School of Public Health. With a robust skill set that includes Clinical Trials, Immunology, Business Strategy, Strategic Planning, Pharmaceuticals, Ilana Fogelman demonstrates proficiency in a wide range of areas.